Beaird Harris Wealth Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-600
| Closed | -$1.78K | – | 512 |
|
|
2024
Q2 | $1.78K | Hold |
600
| – | – | ﹤0.01% | 546 |
|
|
2024
Q1 | $2.72K | Hold |
600
| – | – | ﹤0.01% | 440 |
|
|
2023
Q4 | $3.43K | Hold |
600
| – | – | ﹤0.01% | 417 |
|
|
2023
Q3 | $2.76K | Hold |
600
| – | – | ﹤0.01% | 342 |
|
|
2023
Q2 | $3.88K | Hold |
600
| – | – | ﹤0.01% | 338 |
|
|
2023
Q1 | $4.52K | Hold |
600
| – | – | ﹤0.01% | 326 |
|
|
2022
Q4 | $6.08K | Hold |
600
| – | – | ﹤0.01% | 385 |
|
|
2022
Q3 | $6K | Buy |
+600
| New | +$6K | ﹤0.01% | 322 |
|
|
2022
Q2 | – | Sell |
-600
| Closed | -$6K | – | 399 |
|
|
2022
Q1 | $6K | Buy |
600
+300
| +100% | +$3K | ﹤0.01% | 400 |
|
|
2021
Q4 | $4K | Buy |
+300
| New | +$4K | ﹤0.01% | 485 |
|